Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Gilenia on track to become first oral MS drug

June 11, 2010 Sales and Marketing Gilenia, MS

Novartis’ oral MS therapy Gilenia has been boosted by an FDA committee’s unanimous recommendation for its approval. The drug is …
News

The Research Partnership makes global appointments

June 11, 2010 Sales and Marketing The Research Partnership, appointment, sales and marketing

Market research firm The Research Partnership has made two appointments to its global network of offices. Philippe Pouliot has been …
Appointment

Zactima promising in rare thyroid cancer

June 11, 2010 Research and Development, Sales and Marketing AstraZeneca, thyroid cancer, zactima

AstraZeneca’s Zactima (vandetanib) will be filed with regulators later this year as a treatment for thyroid cancer after promising results. …
News
Genzyme

Genzyme and Icahn agree compromise deal

June 10, 2010 Research and Development, Sales and Marketing Genzyme

Carl Icahn has won his battle with Genzyme to have his associates given a place on the company’s board.The US …
News

NICE rejects GSK’s Revolade

June 10, 2010 Sales and Marketing ITP, NICE, Revolade

NICE has rejected GlaxoSmithKline’s Revolade saying in draft guidance that the blood disorder drug’s benefits were unclear. The watchdog assessed …
News
TyverbWeb

NICE says no to GSK breast cancer drug

June 10, 2010 Sales and Marketing NICE, Tyverb

NICE has issued final draft guidance restricting use of GlaxoSmithKline’s breast cancer drug Tyverb to clinical trials, citing high cost …
News

EU regulators to assess potential lupus breakthrough drug

June 8, 2010 Sales and Marketing Benlysta, Human Genome Sciences, Lupus

GlaxoSmithKline and Human Genome Sciences have submitted a marketing application to the European Medicines Agency for their new lupus drug. …
News

CME Spotlight: Power to the people

June 8, 2010 Medical Communications, Sales and Marketing CME Spotlight, transparency

The UK general election is now over and as we stayed up to watch the count, or woke on the …
Feature

EMA under fire for blocking data access

June 8, 2010 Research and Development, Sales and Marketing Acomplia, Alli, EMA, Xenical, data

The European ombudsman has called for the European Medicines Agency to grant access to clinical study reports and trial protocols …
News
Novo ethics tools

Digital Pharma: Novo Nordisk’s online ethics tools

June 8, 2010 Medical Communications, Sales and Marketing Novo Nordisk, compliance, ethics

Two new e-learning tools have been launched to help shed some light on ethical grey areas and give individuals a …
News

Idis appoints Richard Greatorex

June 8, 2010 Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing

Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …
Appointment
Nexium

AZ submits Nexium-aspirin combination for EU approval

June 7, 2010 Sales and Marketing AstraZeneca, Nexium, aspirin

AstraZeneca is seeking European approval for a new version of its anti-ulcer blockbuster Nexium that combines the pill with aspirin. …
News

NICE rejects Xolair for children

June 3, 2010 Sales and Marketing NICE, Xolair, asthma

The drug was first approved in Europe in November 2005 for patients aged 12 or older, and gained NICE approval …
News

Erbitux ‘now standard of care’ in KRAS patients

June 3, 2010 Sales and Marketing Erbitux, Merck Serono

A new survey suggests Merck Serono’s Erbitux has become a standard of care for KRAS wild-type metastatic colorectal cancer The …
News

Xeloda for gastric cancer gains NICE nod

June 2, 2010 Sales and Marketing UK, Xeloda

NICE has recommended Roche’s Xeloda as a first line treatment of inoperable advanced gastric cancer.The cost-effectiveness body says the oral …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026